Search Within

Heiko Schoder

  1. "Department of Medicine"
Formats
  1. Journal Article (135)
  2. Meeting Abstract (124)
  3. Research Letter (4)
  4. Book Section (1)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Department of Medicine (266)
  2. Molecular Imaging and Therapy Service (266)
  3. Radiology, Department of (266)
  4. Hematologic Malignancies, Division of (153)
  5. Center for Hematologic Malignancies (141)
  6. Solid Tumor Oncology Division (132)

More Groups

People
  1. Andrew Zelenetz (66)
  2. Alison Moskowitz (59)
  3. David Straus (56)
  4. Ariela Noy (55)
  5. Maria Palomba (53)
  6. Paul Hamlin (51)

More People

Years
  1. 2025 (8)
  2. 2024 (26)
  3. 2023 (28)
  4. 2022 (14)
  5. 2021 (21)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (51)
  2. Blood (49)
  3. Journal of Nuclear Medicine (25)
  4. International Journal of Radiation Oncology, Biology, Physics (22)
  5. Hematological Oncology (11)
  6. European Journal of Nuclear Medicine and Molecular Imaging (9)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (51)
  3. Elsevier Inc. (31)
  4. Society of Nuclear Medicine (25)
  5. Springer (19)
  6. Wiley Blackwell (17)

More Publishers

Results (266)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Prostate Cancer Clinical Trials Consortium (PCCTC) bone scan data capture tool for clinical trials using Prostate Cancer Working Group 2 (PCWG2) criteria: Effect on data accuracy and workload
    Meeting Abstract

    Morris, M. J.; Farrelly, J. S.; Fox, J. J.; Dennis, E. R.; Schwartz, L. H.; Schoder, H.; Haupt, E. C.; Borwick, L. S.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Six cycles of ABVD and a negative PET scan negates the need for radiologic follow-up in early stage, non-bulky Hodgkin lymphoma: MSKCC retrospective analysis
    Meeting Abstract

    Hartridge-Lambert, S. K.; Schoder, H.; Lim, R. C.; Maragulia, J. C.; Portlock, C. S.
    Blood (2011)

    Fulltext@MSK | Save
  • Primary tumor metabolic volume improves risk prediction of long-term outcomes in patients with oropharyngeal squamous cell carcinoma treated with intensity modulated radiation therapy (IMRT) and chemotherapy
    Meeting Abstract

    Lim, R. C.; Schoder, H.; Eaton, A.; Gonen, M.; Rao, S.; Sherman, E.; Wong, R.; Setton, J.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • A pilot study of using pre- and early (1 week) [18f]-misonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) scans as an early treatment response predictor in a series of head and neck cancer (HNC) patients undergoing chemoradiation
    Meeting Abstract

    Lee, N.; Bartlett, R.; Lian, M.; Fury, M.; Sherman, E.; Wong, R.; Zanzonico, P. B.; Schoder, H.; Humm, J.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT
    Journal Article

    Fox, J. J.; Autran-Blanc, E.; Morris, M. J.; Gavane, S.; Nehmeh, S.; Van Nuffel, A.; Gonen, M.; Schoder, H.; Humm, J. L.; Scher, H. I.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • FDG-PET in the staging and prognosis of T-cell lymphoma
    Meeting Abstract

    Casulo, C.; Maragulia, J.; Zelenetz, A.; Schoder, H.; Feeney, J.; Horwitz, S.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: Pretreatment prognostic factors and interim PET
    Journal Article

    Straus, D. J.; Johnson, J. L.; LaCasce, A. S.; Bartlett, N. L.; Kostakoglu, L.; Hsi, E. D.; Schoder, H.; Hall, N. C.; Jung, S. H.; Canellos, G. P.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Developing imaging strategies for castration resistant prostate cancer
    Journal Article

    Fox, J. J.; Morris, M. J.; Larson, S. M.; Schoder, H.; Scher, H. I.
    Acta Oncologica (2011)

    Fulltext@MSK | Save
  • Perioperative chemotherapy plus bevacizumab with early salvage therapy based on PET response in patients with locally advanced resectable gastric/GEJ cancer
    Meeting Abstract

    Smyth, E. C.; Schoder, H.; Coit, D. G.; Strong, V. E.; Brennan, M. F.; Janjigian, Y. Y.; Capanu, M.; Tang, L. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save